Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in AUD
The 3 analysts offering 12 month price targets for Percheron Therapeutics Ltd have a median target of 0.24, with a high estimate of 0.270 and a low estimate of 0.14. The median estimate represents a 140.00% increase from the last price of 0.10.
High | 170.0% | 0.270 |
Med | 140.0% | 0.24 |
Low | 40.0% | 0.14 |
Earnings history & estimates in AUD
Average growth rate | +7.57% |
More ▼
Revenue history & estimates in AUD
Average growth rate | +11,423.05% |
More ▼